5c3t
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | ''' | + | ==PD-1 binding domain from human PD-L1== |
+ | <StructureSection load='5c3t' size='340' side='right' caption='[[5c3t]], [[Resolution|resolution]] 1.80Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[5c3t]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5C3T OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5C3T FirstGlance]. <br> | ||
+ | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4zqk|4zqk]]</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5c3t FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5c3t OCA], [http://pdbe.org/5c3t PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5c3t RCSB], [http://www.ebi.ac.uk/pdbsum/5c3t PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/PD1L1_HUMAN PD1L1_HUMAN]] Involved in the costimulatory signal, essential for T-cell proliferation and production of IL10 and IFNG, in an IL2-dependent and a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation and cytokine production.<ref>PMID:10581077</ref> <ref>PMID:11015443</ref> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Targeting the PD-1/PD-L1 immunologic checkpoint with monoclonal antibodies has recently provided breakthrough progress in the treatment of melanoma, non-small cell lung cancer, and other types of cancer. Small-molecule drugs interfering with this pathway are highly awaited, but their development is hindered by insufficient structural information. This study reveals the molecular details of the human PD-1/PD-L1 interaction based on an X-ray structure of the complex. First, it is shown that the ligand binding to human PD-1 is associated with significant plasticity within the receptor. Second, a detailed molecular map of the interaction surface is provided, allowing definition of the regions within both interacting partners that may likely be targeted by small molecules. | ||
- | + | Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1.,Zak KM, Kitel R, Przetocka S, Golik P, Guzik K, Musielak B, Domling A, Dubin G, Holak TA Structure. 2015 Oct 22. pii: S0969-2126(15)00402-5. doi:, 10.1016/j.str.2015.09.010. PMID:26602187<ref>PMID:26602187</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | + | </div> | |
- | + | <div class="pdbe-citations 5c3t" style="background-color:#fffaf0;"></div> | |
- | + | == References == | |
- | + | <references/> | |
+ | __TOC__ | ||
+ | </StructureSection> | ||
[[Category: Dubin, G]] | [[Category: Dubin, G]] | ||
- | [[Category: Zak, K | + | [[Category: Holak, T A]] |
+ | [[Category: Zak, K M]] | ||
+ | [[Category: Immune system]] | ||
+ | [[Category: Immunology]] | ||
+ | [[Category: Ligand]] | ||
+ | [[Category: Pd1/pdl1 axis]] |
Revision as of 07:18, 9 December 2015
PD-1 binding domain from human PD-L1
|
Categories: Dubin, G | Holak, T A | Zak, K M | Immune system | Immunology | Ligand | Pd1/pdl1 axis